141 related articles for article (PubMed ID: 29043300)
1. Serum AFU, 5'-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis.
Junna Z; Gongde C; Jinying X; Xiu Z
Open Med (Wars); 2017; 12():354-358. PubMed ID: 29043300
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Zhang SY; Lin BD; Li BR
FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
[No Abstract] [Full Text] [Related]
4. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Gan Y; Liang Q; Song X
Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
[TBL] [Abstract][Full Text] [Related]
5. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.
Zhu J; Jiang F; Ni HB; Xiao MB; Chen BY; Ni WK; Lu CH; Ni RZ
Exp Ther Med; 2013 Jan; 5(1):89-94. PubMed ID: 23251247
[TBL] [Abstract][Full Text] [Related]
7. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
Shi X; Zhou Y; Xia L
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
[TBL] [Abstract][Full Text] [Related]
9. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
Hussein TD
Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Combined Serum Marker Tests in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Xie L; Luo X
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37917888
[TBL] [Abstract][Full Text] [Related]
11. Serum AFU, GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value.
Gong G; Zheng K; Xue S; Hou J; Zhang Q
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):111-116. PubMed ID: 33040823
[TBL] [Abstract][Full Text] [Related]
12. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
13. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative serum α-1-fucosidase as an early-recurrent indicator for hepatocellular carcinoma following curative resection].
Zhou Y; Ma X; Wu J; Zhang C; Wang B; Song B; Guo W; Pan B
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3623-8. PubMed ID: 25622951
[TBL] [Abstract][Full Text] [Related]
15. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
16. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
17. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
18. Plasma interleukin 17 in the diagnosis of hepatocellular carcinoma: a retrospective study of 39 cases.
Liu J; Zhou G; Lu W
J Cancer Res Ther; 2014 Dec; 10 Suppl():304-6. PubMed ID: 25693940
[TBL] [Abstract][Full Text] [Related]
19. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
Shen W; Shen DM
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
Hu RZ; Zhao SQ; Shen B; Guo GB
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):634-637. PubMed ID: 31594082
[No Abstract] [Full Text] [Related]
[Next] [New Search]